Sandbox Reserved 1716: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 92: | Line 92: | ||
[https://en.wikipedia.org/wiki/Vitamin_K_antagonist#:~:text=Vitamin%20K%20antagonists%20(VKA)%20are,the%20recycling%20of%20vitamin%20K. Vitamin K Antagonists] are first line therapeutics in the treatment of thromboembolic diseases, like a stroke or heart attack. <ref name=”Goy”>PMID:23034830<ref/>[https://en.wikipedia.org/wiki/Warfarin Warfarin] is the most common medication for this treatment, acting as a blood thinner. Warfarin binding to VKOR prevents the triggering of coagulation factors that form blood clots. | [https://en.wikipedia.org/wiki/Vitamin_K_antagonist#:~:text=Vitamin%20K%20antagonists%20(VKA)%20are,the%20recycling%20of%20vitamin%20K. Vitamin K Antagonists] are first line therapeutics in the treatment of thromboembolic diseases, like a stroke or heart attack. <ref name=”Goy”>PMID:23034830<ref/>[https://en.wikipedia.org/wiki/Warfarin Warfarin] is the most common medication for this treatment, acting as a blood thinner. Warfarin binding to VKOR prevents the triggering of coagulation factors that form blood clots. | ||
</StructureSection> | |||
== References == | == References == | ||
<references/> | <references/> | ||
